placeholder image
J. Van Otterloo All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Effectiveness of 2023-2024 coronavirus disease 2019 (COVID-19) vaccines in pregnant women. 
    Obstetrics and Gynecology. 2026
  • Effectiveness of RSV prevention strategies in US infants: 2024-2025. 
    Pediatrics. 2026
  • Estimated effectiveness of 2024-2025 COVID-19 vaccines in adults. 
    JAMA internal medicine. 2026
  • Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024. 
    Vaccine. 2026
  • Influenza vaccine effectiveness against influenza-associated hospitalizations and emergency department or urgent care encounters among children and adults - United States, 2024-25 season. 
    medRxiv. 2026
  • Influenza vaccine effectiveness against influenza-associated hospitalizations and emergency department or urgent care encounters among children and adults-VISION, United States, 2024-2025 season. 
    Open forum infectious diseases. 2026
  • Effectiveness of 2023-2024 seasonal influenza vaccine against influenza-associated emergency department and urgent care encounters among pregnant and non-pregnant women of reproductive age. 
    Vaccine. 2025
  • Effectiveness of 2024-2025 COVID-19 vaccines in children in the United States - VISION, August 29, 2024-September 2, 2025. 
    MMWR: Morbidity and Mortality Weekly Report. 2025
  • Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysis. 
    Lancet Reg Health Am. 2025
  • Estimated 2023-2024 COVID-19 vaccine effectiveness in adults. 
    JAMA network open. 2025
    • Contact
    full name
  • J. Van Otterloo
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration